251 results on '"Vasen, Hans F.A."'
Search Results
2. Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis
3. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study
4. Diet quality and colorectal tumor risk in persons with Lynch syndrome
5. THE ADDED VALUE OF BLOOD GLUCOSE MONITORING IN HIGH-RISK INDIVIDUALS UNDERGOING PANCREATIC CANCER SURVEILLANCE
6. Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a hereditary pancreatic cancer surveillance program
7. Endoscopic full thickness resection for early colon cancer in Lynch syndrome
8. The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriers
9. Supplementary Figure Legends 1-2 from Infiltration of Lynch Colorectal Cancers by Activated Immune Cells Associates with Early Staging of the Primary Tumor and Absence of Lymph Node Metastases
10. Supplementary Table 1 from Infiltration of Lynch Colorectal Cancers by Activated Immune Cells Associates with Early Staging of the Primary Tumor and Absence of Lymph Node Metastases
11. Supplementary Figure 2 from Infiltration of Lynch Colorectal Cancers by Activated Immune Cells Associates with Early Staging of the Primary Tumor and Absence of Lymph Node Metastases
12. Supplementary Figure 1 from Infiltration of Lynch Colorectal Cancers by Activated Immune Cells Associates with Early Staging of the Primary Tumor and Absence of Lymph Node Metastases
13. Comparison of pancreatic cancer outcomes diagnosed in surveillance and the general population: A propensity score-matched analysis.
14. Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up
15. Surveillance for hereditary cancer: Does the benefit outweigh the psychological burden?—A systematic review
16. Surgical management for advanced duodenal adenomatosis and duodenal cancer in Dutch patients with familial adenomatous polyposis: A nationwide retrospective cohort study
17. Smoking Increases the Risk for Colorectal Adenomas in Patients With Lynch Syndrome
18. Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families
19. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A
20. MUTYH-associated polyposis (MAP)
21. Magnetic Resonance Imaging Surveillance Detects Early-Stage Pancreatic Cancer in Carriers of a p16-Leiden Mutation
22. One to 2-Year Surveillance Intervals Reduce Risk of Colorectal Cancer in Families With Lynch Syndrome
23. Risk and Epidemiological Time Trends of Gastric Cancer in Lynch Syndrome Carriers in The Netherlands
24. Analysis of MUTYH Genotypes and Colorectal Phenotypes in Patients With MUTYH-Associated Polyposis
25. Variation in the Risk of Colorectal Cancer for Lynch Syndrome: A retrospective family cohort study
26. Desmoid Tumors in a Dutch Cohort of Patients With Familial Adenomatous Polyposis
27. Risk of Developing Adenomas and Carcinomas in the Ileal Pouch in Patients With Familial Adenomatous Polyposis
28. Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis
29. Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up.
30. Effect of Aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome
31. Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants
32. Associations of Height with the Risks of Colorectal and Endometrial Cancer in Persons with Lynch Syndrome
33. Is a colorectal neoplasm diagnosis a trigger to change dietary and other lifestyle habits for persons with Lynch syndrome? A prospective cohort study
34. Genotype-Phenotype Correlations as a Guide in the Management of Familial Adenomatous Polyposis
35. Combined analysis of three lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers
36. Decrease in Mortality in Lynch Syndrome Families Because of Surveillance
37. Heterozygous Mutations in PMS2 Cause Hereditary Nonpolyposis Colorectal Carcinoma (Lynch Syndrome)
38. Prospective Results of Surveillance Colonoscopy in Dominant Familial Colorectal Cancer With and Without Lynch Syndrome
39. A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses
40. Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer
41. Quantification of Sequence Exchange Events between PMS2 and PMS2CL Provides a Basis for Improved Mutation Scanning of Lynch Syndrome Patients
42. A Cell-Free Assay for the Functional Analysis of Variants of the Mismatch Repair Protein MLH1
43. Survival of MUTYH-associated polyposis patients with colorectal cancer and matched control colorectal cancer patients
44. A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients
45. Screening behavior of individuals at high risk for colorectal cancer
46. Genetic testing in familial melanoma: uptake and implications
47. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer
48. Transanal minimally invasive surgery (TAMIS) versus endoscopic submucosal dissection (ESD) for resection of non-pedunculated rectal lesions (TRIASSIC study): Study protocol of a European multicenter randomised controlled trial
49. Prevalence of Adenomas among Young Individuals at Average Risk for Colorectal Cancer
50. The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.